课题基金 / 基金详情

STRUCTURAL STUDY OF EPH RECEPTORS

STRUCTURAL STUDY OF EPH RECEPTORS
EPH受体的结构研究
批准号:
8363564
负责人:
DIMITAR B NIKOLOV
金额:
$0.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2012-06-30

项目摘要

项目成果

DIMITAR B NIKOLOV的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Eph receptor tyrosine kinases and their ephrin ligands regulate cell navigation during normal and oncogenic development. Signaling of Ephs is initiated in a multistep process leading to the assembly of higher-order signaling clusters that set off bidirectional signaling in interacting cells. However, the structural and mechanistic details of this assembly remained undefined. We request Chess A1 beamtine to determine the structures of the complete EphA4 ectodomain and complexes with ephrin-A5 as the base unit of an Eph cluster. We have also obtained crystals of EphA4 bound to a small-molecule inhibitor which we will collect data on. Previous crystallographic data collection on our EphA4 and EphA4/ephrin-A5 crystals reveal diffraction to approximately 4.0 A. We have now, though, improved the size and quality of the crystals, and expect that we will be able to collect higher-resolution data. The structures will be determined using molecular replacement with known structures of fragments of other Eph receptors which share significant sequence identity (50%) to EphA4. We have also previously determined the structure of unbound ephrin-A5.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the alpha secretase ADAM10 for the treatment of Alzheimer's disease
  • 批准号:
    10590899
  • 项目类别:
  • 资助金额:
    $26.55万
  • 财政年份:
    2022
  • 负责人:
    DIMITAR B NIKOLOV
  • 依托单位:
Molecular mechanisms of Tie2/Angiopoietin signaling initiation
  • 批准号:
    9159077
  • 项目类别:
  • 资助金额:
    $44.81万
  • 财政年份:
    2016
  • 负责人:
    DIMITAR B NIKOLOV
  • 依托单位:
Molecular mechanisms of Tie2/Angiopoietin signaling initiation
  • 批准号:
    9321086
  • 项目类别:
  • 资助金额:
    $44.81万
  • 财政年份:
    2016
  • 负责人:
    DIMITAR B NIKOLOV
  • 依托单位:
Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis
  • 批准号:
    9024489
  • 项目类别:
  • 资助金额:
    $19.13万
  • 财政年份:
    2015
  • 负责人:
    DIMITAR B NIKOLOV
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: